Nurse-Led Caregiver Support for Older Adults With Advanced Lung Cancer
NCT07708870
Summary
This two-phase study aims to examine the current status of older adults with newly diagnosed locally advanced or advanced non-small cell lung cancer and their primary family caregivers, and to evaluate the effects of the Integrating Nurse-Led and Resource Utilization-Based Caregiver Support Model (ICSM). Phase I is a cross-sectional correlational study assessing distress, unmet care needs, resource awareness and utilization, social support, and health promotion practice. Phase II is a two-group randomized controlled trial comparing ICSM plus oncology case manager care with oncology case manager care and usual hospital care. The intervention includes nurse-led education and counseling, symptom management, emotional coping, problem-solving, social resource use, caregiving activity arrangement, and use of a web-based or LINE-based integrated resource system.
Eligibility
Inclusion Criteria: Patient inclusion criteria: * Older adults with newly diagnosed locally advanced or advanced non-small cell lung cancer. * Stage III or stage IV non-small cell lung cancer. * Aware of their cancer diagnosis. * Preparing to receive anti-cancer medical treatment. * Able to communicate verbally and complete study assessments. * Willing to participate in the study and provide written informed consent. Caregiver inclusion criteria: * Adult aged 18 years or older. * Identified by the eligible patient as the fixed primary family caregiver. * Able to participate in the study together with the patient as a patient-caregiver dyad. * Willing to participate in the study and provide written informed consent. Exclusion Criteria: Patient exclusion criteria: \- Severe cognitive impairment that prevents completion of study questionnaires or assessments. Caregiver exclusion criteria: * Unable to communicate sufficiently to complete study assessments. * Unable or unwilling to provide written informed consent.
Conditions6
Browse More Trials
Trial data from ClinicalTrials.gov. Trial status and eligibility can change — verify directly with the study contact or on ClinicalTrials.gov.
This site does not provide medical advice. Always consult your doctor before considering enrollment in a clinical trial. Learn more on our About page.
NCT07708870